Request for Covid-19 Impact Assessment of this Report
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.
The global Biosimilars market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Injection
Tablets
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy’s Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Biosimilars Picture
1.1.2 Specifications
Table Product Specifications of Biosimilars
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Biosimilars
Table Global Biosimilars Market by Type, 2011-2022 (USD Million)
1.2.1.1 Injection
Table Injection Overview
1.2.1.2 Tablets
Table Tablets Overview
1.2.1.3 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Biosimilars
Table Global Biosimilars Market by Application, 2011-2022 (USD Million)
1.2.2.1 Ankylosing Spondylitis
Table Ankylosing Spondylitis Overview
1.2.2.2 Tumor
Table Tumor Overview
1.2.2.3 Rheumatoid Arthrtis
Table Rheumatoid Arthrtis Overview
1.2.2.4 Cardiovascular
Table Cardiovascular Overview
1.2.3 by Regions
Table Global Biosimilars Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Biosimilars
2.2 Upstream
Table Cost of Biosimilars
Figure Manufacturing Process of Biosimilars
2.3 Market
2.3.1 SWOT
Figure SWOT of Biosimilars
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Biosimilars
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Biosimilars
3.4 Market Entry
Table Market Entry of Biosimilars
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Injection Market, 2013-2018
Figure Injection Market Size and Growth, 2012-2018 (USD Million)
Figure Injection Market Size and Growth, 2012-2018 (in Volume)
Table Injection CAGR by Revenue and Volume, 2012-2018
4.1.2 Tablets Market, 2013-2018
Figure Tablets Market Size and Growth, 2012-2018 (USD Million)
Figure Tablets Market Size and Growth, 2012-2018 (in Volume)
Table Tablets CAGR by Revenue and Volume, 2012-2018
4.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2018
4.2 Market Forecast
4.2.1 Injection Market Forecast, 2020-2025
Figure Injection Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Injection Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Injection CAGR by Revenue and Volume, 2012-2024
4.2.2 Tablets Market Forecast, 2020-2025
Figure Tablets Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Tablets Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Tablets CAGR by Revenue and Volume, 2012-2024
4.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Ankylosing Spondylitis Market, 2013-2018
Figure Ankylosing Spondylitis Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Ankylosing Spondylitis CAGR by Revenue and Volume, 2012-2018
5.1.2 Tumor Market, 2013-2018
Figure Tumor Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Tumor CAGR by Revenue and Volume, 2012-2018
5.1.3 Rheumatoid Arthrtis Market, 2013-2018
Figure Rheumatoid Arthrtis Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Rheumatoid Arthrtis CAGR by Revenue and Volume, 2012-2018
5.1.4 Cardiovascular Market, 2013-2018
Figure Cardiovascular Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Cardiovascular CAGR by Revenue and Volume, 2012-2018
5.2 Market Forecast
5.2.1 Ankylosing Spondylitis Market Forecast, 2020-2025
Figure Ankylosing Spondylitis Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Ankylosing Spondylitis Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Ankylosing Spondylitis CAGR by Revenue and Volume, 2020-2025
5.2.2 Tumor Market Forecast, 2020-2025
Figure Tumor Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Tumor Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Tumor CAGR by Revenue and Volume, 2020-2025
5.2.3 Rheumatoid Arthrtis Market Forecast, 2020-2025
Figure Rheumatoid Arthrtis Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Rheumatoid Arthrtis Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Rheumatoid Arthrtis CAGR by Revenue and Volume, 2020-2025
5.2.4 Cardiovascular Market Forecast, 2020-2025
Figure Cardiovascular Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Cardiovascular Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Cardiovascular CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Table North America CAGR by Revenue and Volume, 2012-2018
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Table Europe CAGR by Revenue and Volume, 2012-2018
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Table South America CAGR by Revenue and Volume, 2012-2018
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Biosimilars Market by Vendors, 2012-2018 (in Volume)
Table Global Biosimilars Market Share by Vendors, 2012-2018 (USD Million)
Table Global Biosimilars Market Share by Vendors, 2012-2018 (in Volume)
7.2 Market Concentration
Figure Biosimilars Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Sandoz International
Table Sandoz International Profile List
Table Microecological Modulator Operating Data of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Hospira
Table Hospira Profile List
Table Microecological Modulator Operating Data of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Teva Pharmaceutical
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Dr. Reddy’s Laboratories
Table Dr. Reddy’s Laboratories Profile List
Table Microecological Modulator Operating Data of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Biocon
Table Biocon Profile List
Table Microecological Modulator Operating Data of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Mylan
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Amgen
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Celltrion
Table Celltrion Profile List
Table Microecological Modulator Operating Data of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Roche Diagnostics
Table Roche Diagnostics Profile List
Table Microecological Modulator Operating Data of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Merck KGaA
Table Merck KGaA Profile List
Table Microecological Modulator Operating Data of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Biosimilars
Table Products Segment of Biosimilars
Table Global Biosimilars Market by Type, 2011-2022 (USD Million)
Table Injection Overview
Table Tablets Overview
Table Others Overview
Table Application Segment of Biosimilars
Table Global Biosimilars Market by Application, 2011-2022 (USD Million)
Table Ankylosing Spondylitis Overview
Table Tumor Overview
Table Rheumatoid Arthrtis Overview
Table Cardiovascular Overview
Table Global Biosimilars Market by Region, 2011-2022 (USD Million)
Table Cost of Biosimilars
Table Market Dynamics
Table Policy of Biosimilars
Table GDP of Major Countries
Table Technology of Biosimilars
Table Market Entry of Biosimilars
Table Injection CAGR by Revenue and Volume, 2012-2018
Table Tablets CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Injection CAGR by Revenue and Volume, 2012-2024
Table Tablets CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Ankylosing Spondylitis CAGR by Revenue and Volume, 2012-2018
Table Tumor CAGR by Revenue and Volume, 2012-2018
Table Rheumatoid Arthrtis CAGR by Revenue and Volume, 2012-2018
Table Cardiovascular CAGR by Revenue and Volume, 2012-2018
Table Ankylosing Spondylitis CAGR by Revenue and Volume, 2020-2025
Table Tumor CAGR by Revenue and Volume, 2020-2025
Table Rheumatoid Arthrtis CAGR by Revenue and Volume, 2020-2025
Table Cardiovascular CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
Table North America CAGR by Revenue and Volume, 2012-2018
Table Europe CAGR by Revenue and Volume, 2012-2018
Table South America CAGR by Revenue and Volume, 2012-2018
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Biosimilars Market by Vendors, 2012-2018 (in Volume)
Table Global Biosimilars Market Share by Vendors, 2012-2018 (USD Million)
Table Global Biosimilars Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Sandoz International Profile List
Table Microecological Modulator Operating Data of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hospira Profile List
Table Microecological Modulator Operating Data of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy’s Laboratories Profile List
Table Microecological Modulator Operating Data of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Profile List
Table Microecological Modulator Operating Data of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celltrion Profile List
Table Microecological Modulator Operating Data of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Diagnostics Profile List
Table Microecological Modulator Operating Data of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Profile List
Table Microecological Modulator Operating Data of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...